{"id":482759,"title":"Draft guidance document on the collection and analysis of disaggregated data in clinical trials: Overview - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T19:51:49.117000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/draft-collection-analysis-disaggregated-data-clinical-trials.html?wbdisable=true","snippet":"Draft guidance document on the collection and analysis of disaggregated data in clinical trials: Overview The next version of this guidance document will be updated to align with the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Agile Licensing)…","rawSnapshotUrl":"/api/snapshots/raw/482759","browseUrl":"https://replay.healtharchive.ca/job-6/20260106195149/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/draft-collection-analysis-disaggregated-data-clinical-trials.html?wbdisable=true#ha_snapshot=482759","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}